Turning the Tide on Serious Gram-negative Infections: Managed Care Considerations for Improved Patient Outcomes 

A continuing medical education activity sponsored by NAMCP and AAMCN

Turning the Tide on Serious Gram-negative Infections: Managed Care Considerations for Improved Patient Outcomes is a two-part webinar series focusing on the latest developments in the treatment of gram-negative infections

These are archives of live webinars held between July 22 and July 24, 2020

If you participated in any of the live webinars, you are not eligible to claim credit from the archive of that webinar.

By clicking on each of the titles, you will be able to participate in each part.
It is not required that you participate in each, or in order.

These activities are valid from August 1, 2020 to August 1, 2022

This series is supported by an educational grant from Merck Sharp & Dohme Corp.


 
Audience: This activity is intended for healthcare professionals practicing in managed care environments.

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

Description:
Gram-negative bacteria represent an ongoing global healthcare challenge, with changing epidemiology and resistance patterns resulting in increased morbidity and mortality rates among hospitalized patents. Infections caused by Gram-negative bacteria are a significant concern and can have serious consequences. Multidrug-resistant and carbapenem-resistant Gram-negative infections are increasing in prevalence, and their management is complicated by limited treatment options. New antibiotics for preventing and managing these serious infections have recently been introduced, and other agents are in late stages of clinical development. These webinars will take a closer look what managed care professionals need to know about these new options.


Optimizing Antibiotic Therapy in the Treatment of Gram-negative Infections: Recent Advances for Improved Clinical and Economic Outcomes

  1. Summarize the clinical and economic burden of Gram-negative infections and challenges associated with its management
  2. Describe the epidemiology and mechanisms of drug resistance among Gram-negative infections
  3. Outline patient and clinical factors that increase risks for resistant Gram-negative infections
  4. Compare and contrast new and emerging antibiotic options for treating serious Gram-negative infections
  5. Describe strategies to optimize antimicrobial therapy to ensure effectiveness and reduce resistance
       Physician, Nursing and CMCN credits valid to August 1, 2022

Turning the Tide on Serious Gram-negative Infections: Managed Care Considerations for Improved Patient Outcomes

  1. Summarize the economic burden of Gram-negative infections and challenges associated with its management
  2. Compare and contrast new and emerging antibiotic options for treating serious Gram-negative infections
  3. Apply interprofessional strategies for patient-centered Gram-negative infection care, including patient/caregiver education, shared decision-making, and adherence promotion
  4. Assess the managed care considerations of newer antibiotic therapies, by exploring where these agents fit into the current Gram-negative infection management paradigm
       Physician, Nursing and CMCN credits valid to August 1, 2022